Factors affecting aseptic loosening of 4750 total hip arthroplasties: multivariate survival analysis by Bordini, Barbara et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Musculoskeletal Disorders
Open Access Research article
Factors affecting aseptic loosening of 4750 total hip arthroplasties: 
multivariate survival analysis
Barbara Bordini*1, Susanna Stea1, Manuela De Clerico1, Sergio Strazzari2, 
Antonio Sasdelli3 and Aldo Toni1,4
Address: 1Laboratorio di Tecnologia Medica, Istituti Ortopedici Rizzoli Via Barbiano 1/10, 40136 Bologna, Italy, 2Servizio di Farmacia, Istituti 
Ortopedici Rizzoli Via Barbiano 1/10, 40136 Bologna, Italy, 3Direzione Amministrativa, Istituti Ortopedici Rizzoli Via Barbiano 1/10, 40136 
Bologna, Italy and 4I Divisione di Ortopedia e Traumatologia, Istituti Ortopedici Rizzoli Via Barbiano 1/10, 40136 Bologna, Italy
Email: Barbara Bordini* - bordini@tecno.ior.it; Susanna Stea - stea@tecno.ior.it; Manuela De Clerico - declerico@tecno.ior.it; 
Sergio Strazzari - sergio.strazzari@ior.it; Antonio Sasdelli - antonio.sasdelli@ior.it; Aldo Toni - toni@tecno.ior.it
* Corresponding author    
Abstract
Background: Total hip arthroplasty is a successful surgery, that fails at a rate of approximately
10% at ten years from surgery. Causes for failure are mainly aseptic loosening of one or both
components partially due to wear of articular surfaces and partially to design. The present analysis
aimed to identify risk factors and quantify their effects on aseptic failure.
Methods: Multivariate survival analysis was applied to 4,750 primary total hip arthroplasties
performed between 1995 and 2000.
Results: The survival of the prosthesis is affected by gender, age, pathology, type of the prosthesis
and skill of the. The worst conditions are male patients, younger than 40 years, affected by sequelae
of congenital diseases, operated by a who performed less than 400 total hip artroplasty in the
period. Furthermore, cemented cups and stems (less expensive) have a higher risk of failure
compared with uncemented ones (more expensive).
Conclusion: The only variable that affects survival and that can be modified by is the type of
prosthesis: a lower cost is associated to a higher risk. Results concerning the risk associated with
cemented components are partially in disagreement with studies performed in countries where
cemented prostheses are used more often than uncemented ones.
Background
From a surgical point of view, total hip arthroplasty is a
well-standardized operation that has proven to be very
effective. However, failure can sometimes occur in the
immediate postoperative period or even some years after.
According to the NICE guidelines, for a hip prosthesis to
be considered safe its mean survival rate should be at least
90% at ten years [1]. Although the failure rate is low, it
varies greatly and can be influenced by several factors,
such as the type of prosthesis used and the patient's char-
acteristics, and whereas the patient's characteristics are
practically unchangeable, factors related to s and their
choices can be modified. The literature includes numer-
ous studies analysing factors that influence hip prosthesis
failure, but they often concern small series of patients.
Poon observed that weight and age influenced the out-
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come of total hip arthroplasty (THA) using cemented
prostheses [2]. Kobayashi studied a consecutive series of
293 primary cemented Charnley prostheses and found
that rapid wear of polyethylene and abnormal geometry
of the femoral medullary canal affect prosthesis survival
[3]. Kolundzic found that demographic factors explained
only a minor part of the survival variability of 82 cement-
less acetabular cups [4].
The largest series concerned only patients treated using
cemented prostheses. Among them Berry analysed 2000
primary Charnley prostheses at 25 years' follow-up and
found that age, gender and underlying diagnosis affected
long-term survivorship of both components [5]. Dawson
compared 598 cemented prostheses and found no signif-
icant differences between the performance of the two
models [6]. As clearly stated the weakness of all the long-
term studies depends on the fact that they assess the suc-
cess or failure of old technologies and designs [7]. Com-
parison among prostheses with different fixation
(cementless vs cemented) is limited to few clinical trials
that indicate the better performance of cementless com-
ponents. [8-10].
Analyses performed on data from northern European reg-
isters only partially fill this gap since there is a clear-cut
prevalence of cemented prostheses with metal-polyethyl-
ene couplings.
In fact, 93.1% of prostheses implanted in patients in Swe-
den between 1979–2004 [11], and 80% of those used in
Norway between 1987–2004 [12] were cemented. The fig-
ure is lower in Denmark, 49.8% between 1995–2004
[13], and in Finland 55% from 1980–2003 [14]. The data
collected for the UK were only for 2004, and although
they included cemented prostheses in 49% of cases, they
cannot be used for an effective analysis [15].
However, an analysis of the data from the Norwegian
resister Furnes revealed that in over 53,000 operations
some diseases (femoral neck fracture sequelae, congenital
hip dysplasia, and rare diseases) represent risk factors for
prosthesis survival [16].
When limiting the analysis to young osteoarthritic
patients, Eskelinen found that age and gender influence
the result [17].
The Danish register identified age and gender as con-
founding factors in the evaluation of prosthesis survival
[13].
None of these analyses, due to the nature of the opera-
tions analyzed, considered the influence of the type of
prosthesis fixation among the possible risk factors. Only
when analysing the Finish data Visuri find that low age,
male gender, uncemented prostheses and first 10 year-
period of surgery were risk factors for loosening of the
prostheses [18]. Therefore, we analyzed the data of a series
of patients with a minimum of six years' follow-up taken
from the RIPO register (Register of Orthopedic Prosthetic
Implantology), which includes cemented and unce-
mented prostheses, to determine the influence of patient
characteristics, 's experience, and type of prosthesis used,
on the outcome of the operation.
Methods
Materials
A consecutive series of 4,750 primary total hip arthro-
plasties performed on 4,450 patients at Istituto Rizzoli
between 1st January 1995 and 31st December 2000 was
analysed. The number of operations progressively
increased from 1995 (664) to 2000 (847). The patients
were treated in 11 different wards. They underwent regu-
lar clinical evaluation, and if they missed their clinical
examination for longer than 18 months they were con-
tacted by phone, to establish whether the prosthesis was
still in place. The survival of the prosthesis was recorded
at the time of death.
The characteristics of patients are shown in Table 1 and in
Table 2.
They received cemented (12.1%), cementless (51.5%), or
hybrid (36.4%) total hip prostheses.
Femoral and acetabular components were classified on
the basis of their characteristics and economic value. Rel-
ative value was calculated respectively as a ratio to the
value of all-polyethylene cup encompassing the cost of
cement and to the value of a straight cemented stem. In
Table 3 and 4 cups and stem are classified respectively into
three and five groups where the main characteristics and
relevant economic values are reported. Details of the dif-
ferent types of cup/stem that compose each group are also
presented.
The s were classified on the basis of their experience, i.e.
the number of operations performed as primary in the
five-year period. All the surgeons implanted the hip pros-
thesis by lateral approach.
Statistics
Implant survivorship was estimated with use of the Cox
proportional -hazards model [19]. Ninety – five percent
confidence intervals were calculated. The death of a
patient or or the revision of any component was recorded.
All cases that failed due to septic loosening were excluded.
The end point for the acetabular component was revision
of the metal back and/or of the liner. The end-point forBMC Musculoskeletal Disorders 2007, 8:69 http://www.biomedcentral.com/1471-2474/8/69
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the femoral component was revision of the stem and/or of
the modular neck (if present). Revision of the neck due to
head damage was not considered considered as modular
neck failure; in those cases the neck is revised as a precau-
tionary measure, and is not an index of stem failure. For
patients that suffered a cup failure their follow-up time
would not be registered at the date of this failure when
analysing stem failures and viceversa. It was preliminarly
verified that variables entering the model were not differ-
ent among patients suffering for a single component fail-
ure or for contemporary failure of both stem and cup.
Variables included gender, age, diagnosis, Charnley score,
right or left side, surgeon's skill, type of component. Cox
multivariate test enables verification of the influence of
one variable on equal terms with the others.
Results
The results are presented separately for the two main 
components, cup and stem
The chi-square test used to test globally the model applied
was significant if, on the whole, the variables put into the
model influenced significantly the outcome of prosthetic
surgery (chi-square for cup = 52.49; chi-square for stem =
69.604, both significant AT p = 0.001). In the analysis of
cup failure the total number of valid observations was
4,750, of which 4,616 were not removed and 134 were
revised (Table 5). 46 patients out of 134 had cup and stem
failure at the same time.
The outcome is not significantly affected by clinical con-
dition, right or left side, or surgeon's skill. In the analysis
of stem failure the total number of valid observations was
4,750, of which 4,645 were not removed and 86 were
revised.
Outcome is not significantly affected by Charnley score,
side, or diagnosis.(Table 6) Both cup and stem survival are
negatively affected by age under forty, and cemented fixa-
tion of the components. Besides this, the cup survival is
also negatively affected by a preoperative congenital dis-
ease or fracture and sequelae. On the contrary, stem sur-
vival is not affected by the pathology, but is negatively
affected by male gender and lower surgeon skill.
Discussion
To determine the factors that influence component sur-
vival we followed a large number of consecutive primary
total hip arthroplasties performed in the same Institute.
The cohort was large enough to be analysed by age, gen-
der, diagnosis, Charnley score, side, skill of surgeon, and
type of component. Distribution of frequencies of some
variables (ie age at surgery, surgeon experience) is clearly
different among types of implants. Multivariate analysis
Table 1: Characteristics of the studied group. Patients are classified according variables that entered in subsequent multivariate 
analysis
Type of cup
Cemented all polyethylene Press fit, polyethylene liner Press fit, ceramic or 
metal liner
N. (%) N. (%) N. (%)
Gender
Male 137 (24.3) 765 (39.5) 897 (39.9)
Female 426 (75.7) 1173 (60.5) 1352(60.1)
Side
Right 303 (53.8) 1052 (54.3) 1191 (53.0)
Left 260 (46.2) 886 (45.7) 1058 (47.0)
Age at surgery
Lower than 40 2 (0.4) 80 (4.1) 326 (14.5)
Between 40 and 69 151 (26.8) 1311 (67.7) 1503 (66.8)
Higher than 70 410 (72.8) 547 (28.2) 420 (18.7)
Charnley's hip score
Class A 360 (63.9) 1294 (66.8) 1373 (61.0)
Class B+C 203 (36.1) 644 (33.2) 876 (39.0)
Skills of surgeon
Less than 400 operations (68 surgeons) 352 (62.5) 1225 (63.2) 569 (25.3)
More than 400 operations (4 surgeons) 211 (37.5) 713 (36.8) 1680 (74.7)
Diagnosis in primary arthroplasty
Primary arthritis 299 (53.1) 1156 (59.6) 1212 (53.9)
Sequelae of congenital and pediatric diseases 35 (6.2) 321 (16.6) 509 (22.6)
Femoral neck fracture and sequelae 158 (28.1) 272 (14.0) 251 (11.2)
Other 71 (12.6) 189 (9.8) 277 (12.3)BMC Musculoskeletal Disorders 2007, 8:69 http://www.biomedcentral.com/1471-2474/8/69
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applied to test the influence of single factors can limit this
bias. By analysing prostheses implanted between 1995–
2000, we were able to include designs that are still mod-
ern, and at the same time have a long enough follow-up
to highlight any failures.
Since the register was started at Rizzoli Institute in 1990,
all patients have been monitored; if patients fail to attend
scheduled clinical exams, they are contacted by phone or
asked to fill in a questionnaire. This was acceptable as the
recorded end-point (revision) was independent of clinical
examination. The chosen end-point is undoubtedly a raw
parameter, which does not take into account the quality of
life and restoration of function in the treated limb, but its
strength lies precisely in its objectivity.
Some of the results obtained from this analysis support
data reported by other authors in comparable series. In
agreement with the literature, the risk of failure is
increased by male gender, young age, and certain diseases
[17,18,20]. These variables, which constitute the patient's
characteristics, are unchangeable. However, knowing the
influence they can have enables a correct statistical inter-
pretation. The interesting finding that has emerged from
this study is that among the factors that influence the risk
of failure are the surgeon's skill, and the type of prosthe-
sis-to-bone fixation used.
The surgeon's skill is an extremely delicate aspect, which
might depend on the reliability of the hospital where the
operation is performed rather than the experience of the
single surgeon. High-risk patients, who are often admitted
to hospitals not necessarily near home, might be treated
more safely in highly specialised centres. It should be
remembered that the data presented in this study come
from operations performed at a highly specialised hospi-
Table 2: Characteristics of the studied group. Patients are classified according variables that entered in subsequent multivariate 
analysis
Type of stem
Straight 
cemented
Anatomic cemented or 
straight cemented with 
particular design
Straight 
cementless
Surface treated or 
anatomic 
cementless
Modular 
cementless
N. (%) N. (%) N. (%) N. (%) N. (%)
Gender
Male 482 (32.7) 167 (39.5) 300 (38.4) 414 (37.6) 436 (45.0)
Female 994 (67.3) 256 (60.5) 482 (61.6) 687 (62.4) 532 (55.0)
Side
Right 829 (56.2) 227 (53.7) 398 (50.9) 588 (53.4) 504 (52.1)
Left 647 (43.8) 196 (46.3) 384 (49.1) 513 (46.6) 464 (47.9)
Age at surgery
Lower than 40 25 (1.7) 5 (1.2) 159 (20.3) 92 (8.4) 127 (13.1)
Between 40 and 69 748 (50.7) 256 (60.5) 574 (73.4) 663 (60.2) 724 (74.8)
Higher than 70 703 (47.6) 162 (38.3) 49 (6.3) 346 (31.4) 117 (12.1)
Charnley's hip 
score
Class A 937 (63.5) 304 (71.9) 511 (65.3) 670 (60.9) 605 (62.5)
Class B+C 539 (36.5) 119 (28.1) 271 (34.7) 431 (39.1) 363 (37.5)
Skills of surgeon
Less than 400 
operations (68 
surgeons)
710 (48.1) 393 (92.9) 538 (68.8) 378 (34.3) 127 (13.1)
More than 400 
operations (4 
surgeons)
766 (51.9) 30 (7.1) 244 (31.2) 723 (65.7) 841 (86.9)
Diagnosis in 
primary 
arthroplasty
Primary arthritis 831 (56.3) 296 (70.0) 321 (41.1) 676 (61.4) 543 (56.1)
Sequelae of 
congenital and 
pediatric diseases
155 (10.5) 28 (6.6) 278 (35.5) 171 (15.5) 233 (24.1)
Femoral neck 
fracture and 
sequelae
300 (20.3) 70 (16.5) 81 (10.4) 141 (12.8) 89 (9.2)
Other 190 (12.9) 29 (6.9) 102 (13.0) 113 (10.3) 103 (10.6)BMC Musculoskeletal Disorders 2007, 8:69 http://www.biomedcentral.com/1471-2474/8/69
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tal and includes very complex cases, which, on the other
hand, have been treated by highly specialised surgeons.
Another important factor that can be modified is the pros-
thetic component. Uncemented components are gener-
ally much less likely to fail than cemented ones. However,
our results appear to be in contrast with those of other reg-
isters [11]. Nevertheless, reading the data more carefully
reveals that as experience using uncemented components
increases, the difference in results between the two types
of prostheses decreases, and the efficacy of uncemented
prostheses is highlighted especially with regards to young
[12,17] or middle-aged patients [13].
An interesting finding that emerged from our study was
that the more expensive the prosthesis, the longer its sur-
vival was.
With regards to the cup, all other variables being equal,
compared to the monoblock polyethylene cup the failure
rate of the press-fit cup with a polyethylene liner, which
costs four times more than the monoblock cup, was
reduced by half, and reduced by 2/3 when using the press-
fit cup with a ceramic liner, which costs five times more
than the monoblock cup.
Concerning the stem, there were no significant differences
in the failure rate between the straight cemented stem and
the anatomical cemented stem, which costs 10% more.
Conversely, compared to the cemented straight stem, the
failure rate of the uncemented straight stem, which costs
90% more than the cemented one, is 60% less. The reduc-
tion in the failure rate is 60% also when using unce-
mented modular stems, which cost 150% more than the
cemented straight stem.
Table 4: Distribution of implanted stems, according to fixation 
and design
Stem Relative value n. implants
Straight cemented stem 1.00 1476
473 LC Samo,
344 AHS Cremascoli,
198 Definition Howmedica,
169 Exeter Howmedica,
103 Gemini De Puy,
70 self-locking Sulzer,
other types with less than 50 implants 
each
Anatomic cemented or straight cemented 
with particular design
1.16 423
228 Elite De Puy,
191 Lubinus SP 2 Link,
other types with less than 100 implants 
each.
Straight cementless 1.88 782
502 Cone prosthesis Sulzer,
120 Meridian Howmedica,
85 CLS Sulzer,
62 Metabloc Sulzer,
other types each with less than 50 
implants.
Surface treated or anatomic 
cementless
2.10 1101
567 Anca Cremascoli,
194 Duofit RKT Samo,
125 PCA Howmedica,
98 Citation Howmedica,
77 AML Depuy stems
other types each with less than 50 
implants
Modular cementless 2.46 968
869 Anca Fit Cremascoli,
86 Dual fit Cremascoli stems,
other types each with less than 10 
implants
Total 4750
Table 3: Distribution of implanted cups, according to fixation 
and type of liner
Cup Relative value n. implants
Cemented all polyethylene 1.00 563
135 Contemporary Howmedica 
(Mahwah, New Jersey, USA)
149 Muller Cremascoli (Milano, Italy),
130 Muller Sulzer (Geneve, Switzerland),
54 Exeter Howmedica,
other types with less than 50 implants 
each.
Press fit, polyethylene liner 3.73 1938
375 Duraloc De Puy (Warsaw, Indiana, 
USA)
343 Fitek Sulzer,
336 Duofit PSF Samo (Bologna, Italy),
250 ABG Howmedica,
123 Vitalock Talon Howmedica,
105 PCA Howmedica,
other types with less than 100 implants 
each.
Press fit, ceramic or metal liner 4.94 2249
1548 AnCA Fit Cremascoli,
276 Duofit PSF Samo,
144 Fitek Sulzer,
133 Standard Cup Protek
other types with less than 100 implants 
each
Total 4750BMC Musculoskeletal Disorders 2007, 8:69 http://www.biomedcentral.com/1471-2474/8/69
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Finally, coated and/or anatomical uncemented stems cost
110% more than cemented straight stems but the failure
rate is reduced by 80%.
All the conclusions drawn from these data have intrinsic
and unavoidable limits due to the low rate of revision
(less than 3%) that affect primary Total Hip Arthroplasty.
The revision rate is fortunately lower than the 10% sug-
gested as the maximum acceptable by NICE [1]. For this
reason a non-parametric statistical method of analysis was
used, which can handle correctly this kind of data.
This analysis provides the basis for a cost-benefit assess-
ment, which aims at determining whether a certain clini-
cal result can be achieved while reducing the resources
used. From a strictly ethical point of view the results give
a clear indication of the choice, but the availability of eco-
nomic resources can only be determined by healthcare
policy. Undoubtedly, subsequent cost-benefit analysis
should take into account that this type of operation is per-
formed on elderly people who need a long recovery
period. Therefore, there is also a need for rehabilitation
centres, which are often lacking, and so elderly people
often have to rely on the help of their families.
Besides social aspects, also technical difficulties should
not be underestimated. Sometimes surgeons are faced
with difficult operations and have to make bold choices.
However, cost-benefit analysis is not within the scope of
this paper, which is limited to providing data to enable
correct elaboration [21,22]. We reiterate that the data pre-
sented come from a series of patients and include the use
of cemented and uncemented components, unlike those
based on large databanks of northern European registers,
which show that cemented components perform better
[23,24] or at least as well as [25] uncemented ones. Since
cemented prostheses are cheaper, they are more advanta-
geous from a cost-benefit point of view. The data we have
presented, which do not include only the cost of materials
[26] will enable a cost-benefit analysis that is closer to
reality in countries where the use of uncemented prosthe-
ses is more widespread.
Conclusion
The only variable that affects survival and that can be
modified by surgeon is the type of prosthesis: a lower cost
is associated to a higher risk. Results concerning the risk
associated with cemented components are partially in dis-
agreement with studies performed in countries where
Table 5: Results of multivariate analysis of cup failure
Failures/I Implants Unadjusted (95% CI) Adjusted for all variables 
(95% CI)
P
Gender
Female 82/2951 1 (referent) 1(referent)
Male 52/1799 1.12 (0.79–1.58) 0.76 (0.53–1.10) p = 0.16
Side
Left 60/2204 1 (referent) 1 (referent)
Right 74/2546 1.08 (0.77–1.52) 1.16(0.82–1.63) p = 0.34
Age at surgery P --trend=0.005
Between 40 and 69 86/2965 1 (referent) 1 (referent)
Higher than 70 27/1377 0.75 (0.49–1.16) 0.66 (0.41–1.08) p = 0.098
Lower than 40 21/408 1.99 (1.24–3.21) 2.02 (1.21–3.38) p = 0.007
Charnley's hip score
Class A 78/3027 1 (referent) 1(referent)
Class B+C 56/1723 1.12 (0.79–1.57) 1.15 (0.81–1.63) p = 0.42
Skills of surgeon
More than 400 operations 63/2604 1 (referent) 1 (referent)
Less than 400 operations 71/2146 1.46 (1.04–2.05) 1.23 (0.85–1.77) p = 0.27
Type of cup P --trend=0.004
Press fit, ceramic or metal 
liner
50/2249 1 (referent) 1 (referent)
Cemented all polyethylene 23/563 1.84 (1.12–3.01) 2.68 (1.48–4.83) p = 0.001
Press fit, polyethylene liner 61/1938 1.42 (0.98–2.06) 1.53 (1.02–2.29) p = 0.04
Diagnosis in primary 
arthroplasty
P --trend=0.0001
Primary arthritis 51/2667 1 (referent) 1 (referent)
Sequelae of congenital and 
pediatric diseases
44/865 2.44 (1.63–3.65) 2.32 (1.49–3.62) p = 0.0001
Femoral neck fracture and 
sequelae
29/681 2.41 (1.53–3.80) 1.98 (1.24–3.17) p = 0.004
Other 10/537 0.99 (0.50–1.95) 0.46 (0.38–1.55) p = 0.46BMC Musculoskeletal Disorders 2007, 8:69 http://www.biomedcentral.com/1471-2474/8/69
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cemented prostheses are used more often than unce-
mented ones.
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